Results 81 to 90 of about 260,112 (235)

Perceived Barriers to Accessing Tuberculosis Care Among Multidrug Resistant Tuberculosis (MDR-TB) Patients: A Qualitative Study in Indonesia [PDF]

open access: yes, 2020
- Indonesia has one of the highest MDR-TB burdens in the world. The success rate of MDR-TB treatment in Indonesia is still low. Indonesia changed the health system policy, which is called the National Health Insurance,in 2013.
Tutik Kusmiati, -   +4 more
core  

Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar

open access: yesPLOS ONE, 2018
The Union in collaboration with national TB programme (NTP) started the community-based MDR-TB care (CBMDR-TBC) project in 33 townships of upper Myanmar to improve treatment initiation and treatment adherence. Patients with MDR-TB diagnosed/registered under NTP received support through the project staff, in addition to the routine domiciliary care ...
Pyae Phyo Wai   +10 more
openaire   +4 more sources

A Thiosemicarbazone Schiff Base and Its Titanium(IV) Complexes: Spectral Analysis, DFT Studies, and Biological Evaluation

open access: yesChemistry &Biodiversity, Volume 23, Issue 9, September 2026.
DFT computations are used to analyze the electronic structure, stability, and reactivity profiles of a new Schiff base ligand and its Ti(IV) complexes and are characterized by elemental analysis, IR, 1H NMR, 13C NMR, and mass spectrometry and screened for antimicrobial activities against E. coli, S. aureus, ESBL, MRSA, Mtb, A.
Priyanka Ghanghas   +6 more
wiley   +1 more source

Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review.

open access: yesPLoS ONE, 2009
BackgroundTuberculosis (TB) is an important cause of human suffering and death. Human immunodeficiency virus (HIV), multi-drug resistant TB (MDR-TB), and extensive drug resistant tuberculosis (XDR-TB) have emerged as threats to TB control.
Sujit Suchindran   +2 more
doaj   +1 more source

High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors.

open access: yesPLoS ONE, 2011
IntroductionIn high multidrug resistant (MDR) tuberculosis (TB) prevalence areas, drug susceptibility testing (DST) at diagnosis is recommended for patients with risk factors for MDR.
Larissa Otero   +7 more
doaj   +1 more source

Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients’ perspectives from a focus group discussion

open access: yesBMC Public Health, 2020
Background Molecular diagnostics have revolutionized the diagnosis of multidrug resistant tuberculosis (MDR-TB). Yet in Tanzania we found delay in diagnosis with more than 70% of MDR-TB patients having a history of several previous treatment courses for ...
Stellah G. Mpagama   +6 more
doaj   +1 more source

Tuberculosis Misdiagnosed as Bronchogenic Carcinoma: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT The patient, a 77‐year‐old male smoker, presented to the Emergency Department with dyspnea, cough, fever, night sweats, and 12 kg weight loss, initially suggesting COPD or lung cancer. Chest CT revealed a right upper lobe mass, pleural effusion, and lymphadenopathy, prompting suspicion of malignancy.
Pejman Hosseinzadeh   +4 more
wiley   +1 more source

Obstructive Jaundice due to a Periportal Tuberculous Mass Complicated by Anti‐Tuberculous Drug‐Induced Liver Injury: A Case Report From a Low‐Resource Setting

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Periportal tuberculous lymphadenitis with obstructive jaundice is rare and may mimic malignancy. We report a case of obstructive jaundice caused by a periportal tuberculous mass confirmed by fine‐needle aspiration and GeneXpert. Treatment was complicated by anti‐tuberculous drug‐induced liver injury.
Girma Deshimo Lema   +9 more
wiley   +1 more source

CTSs’ attitude towards MDR-TB.

open access: yes, 2022
CTSs’ attitude towards MDR-TB.
J. Christo Heunis (13046945)   +3 more
core   +1 more source

Mitigating treatment failure of pulmonary pre-extensively drug-resistant tuberculosis: The role of new and repurposed drugs

open access: yesJournal of Microbiology, Immunology and Infection
Background: Pre-extensively drug-resistant tuberculosis (pre-XDR-TB), defined as multidrug-resistant TB (MDR-TB) with additional resistance to any fluoroquinolone (FQ) is difficult to treat.
Yi-Wen Huang   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy